Historical record - last NADAC effective date: 1/15/2021
Product Information
REBIF 22 MCG/0.5 ML SYRINGE is a brand product labeled by EMD Serono, Inc., priced at $1400.9343 per ML under NDC 44087002203. Its NADAC has been published 417 times since Jan 22, 2014.
Strength
22 ug/.5mL
Manufacturer
EMD Serono, Inc.NDC
44087002203
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
1/15/2021
Active Ingredients
INTERFERON BETA-1AApproval Type
Biologic (BLA)
FDA Application
BLA103780On Market Since
3/7/2002
Pharmacological Classes
Price Statistics
The NADAC for REBIF 22 MCG/0.5 ML SYRINGE has been published 417 times since Jan 22, 2014, and over the history we have for it it has risen 83.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1400.9343 per ML |
|---|---|
| All-time high | $1400.9343 (Jan 12, 2022) |
| All-time low | $763.5440 (Jan 22, 2014) |
| Median price | $1085.2981 |
| Average price | $1094.2365 |
| Largest weekly change | +7.0% (Oct 15, 2014) |
| Weeks tracked | 417 |
| Tracking since | Jan 22, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
0.0%
All
+83.5%
Last surveyed Jan 12, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the INTERFERON BETA-1A market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
EMD Serono, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
INTERFERON BETA-1A market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of REBIF 22 MCG/0.5 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for REBIF 22 MCG/0.5 ML SYRINGE, manufactured by EMD Serono, Inc., is $1400.9343 per ML (NDC 44087002203), effective Jan 12, 2022.
How has the price of REBIF 22 MCG/0.5 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for REBIF 22 MCG/0.5 ML SYRINGE has risen 83.5%. It has been tracked across 417 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for REBIF 22 MCG/0.5 ML SYRINGE?
Since Jan 22, 2014, the NADAC for REBIF 22 MCG/0.5 ML SYRINGE has ranged from a low of $763.5440 (Jan 22, 2014) to a high of $1400.9343 (Jan 12, 2022), with a median of $1085.2981 per ML.
Are there cheaper alternatives to REBIF 22 MCG/0.5 ML SYRINGE?
No other NADAC-published product currently shares the active ingredient and strength of REBIF 22 MCG/0.5 ML SYRINGE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures REBIF 22 MCG/0.5 ML SYRINGE?
REBIF 22 MCG/0.5 ML SYRINGE (NDC 44087002203) is labeled by EMD Serono, Inc., and CMS classifies it as a brand product.